AXNX [NASD]
Axonics, Inc.
Index- P/E- EPS (ttm)-1.81 Insider Own0.90% Shs Outstand45.34M Perf Week11.38%
Market Cap2.17B Forward P/E- EPS next Y-1.64 Insider Trans-41.09% Shs Float41.67M Perf Month-23.09%
Income-80.20M PEG- EPS next Q-0.55 Inst Own- Short Float10.39% Perf Quarter-2.22%
Sales194.30M P/S11.18 EPS this Y-25.20% Inst Trans0.71% Short Ratio7.93 Perf Half Y-20.85%
Book/sh10.22 P/B4.82 EPS next Y33.20% ROA-14.60% Target Price71.12 Perf Year-9.44%
Cash/sh4.84 P/C10.19 EPS next 5Y- ROE-16.50% 52W Range38.41 - 79.81 Perf YTD-11.95%
Dividend- P/FCF- EPS past 5Y-22.00% ROI-15.00% 52W High-38.22% Beta0.58
Dividend %- Quick Ratio9.60 Sales past 5Y- Gross Margin66.20% 52W Low28.38% ATR3.81
Employees517 Current Ratio12.00 Sales Q/Q40.70% Oper. Margin-38.00% RSI (14)45.04 Volatility5.43% 8.39%
OptionableYes Debt/Eq0.00 EPS Q/Q12.00% Profit Margin-41.30% Rel Volume0.97 Prev Close48.62
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume545.73K Price49.31
Recom1.60 SMA20-4.68% SMA50-13.01% SMA200-17.85% Volume532,178 Change1.42%
Apr-06-22Initiated Wolfe Research Outperform $69
Mar-02-22Resumed BofA Securities Buy $70
Jul-12-21Initiated Barclays Overweight $74
Jun-28-21Reiterated Needham Buy $72 → $78
Nov-05-20Reiterated Needham Buy $57 → $62
Oct-23-20Initiated Guggenheim Buy $77
Sep-02-20Initiated Robert W. Baird Outperform $52
Aug-07-20Reiterated Needham Buy $48 → $57
Jan-08-20Initiated SunTrust Buy $38
Nov-01-19Initiated Piper Jaffray Overweight $39
Oct-21-19Initiated Barclays Overweight $43
Sep-17-19Initiated SVB Leerink Outperform $45
Sep-09-19Reiterated Needham Buy $43 → $48
Sep-03-19Initiated Needham Buy $43
Jun-13-19Reiterated BofA/Merrill Buy $30 → $35
Nov-26-18Initiated Wells Fargo Outperform $22
Nov-26-18Initiated SunTrust Buy $20
Nov-26-18Initiated Morgan Stanley Overweight $21
Nov-26-18Initiated BofA/Merrill Buy $23
May-05-22 05:45PM  
04:01PM  
May-02-22 08:19AM  
Apr-28-22 03:02PM  
Apr-26-22 06:00AM  
Apr-19-22 06:00AM  
Apr-14-22 04:01PM  
Apr-04-22 06:00AM  
Mar-23-22 09:28AM  
Mar-07-22 04:01PM  
Feb-24-22 06:20PM  
04:01PM  
Feb-23-22 05:25PM  
Feb-17-22 03:02PM  
Feb-14-22 05:15PM  
Feb-05-22 06:48AM  
Feb-03-22 06:00AM  
Feb-02-22 01:38PM  
Feb-01-22 06:00AM  
Jan-25-22 06:00AM  
Jan-07-22 08:13AM  
Jan-06-22 06:00AM  
Dec-11-21 05:38AM  
Nov-30-21 06:00AM  
Nov-17-21 06:00AM  
05:01AM  
Nov-09-21 12:14PM  
Nov-08-21 06:00AM  
Nov-07-21 06:57AM  
Nov-05-21 10:30AM  
Nov-04-21 05:55PM  
04:01PM  
Oct-26-21 06:00AM  
Oct-25-21 04:10PM  
Oct-07-21 07:00AM  
Sep-23-21 09:59AM  
Sep-22-21 06:08PM  
Sep-13-21 05:19PM  
Sep-02-21 06:12AM  
Aug-27-21 06:00AM  
Aug-09-21 01:48AM  
Aug-05-21 05:45PM  
04:01PM  
Jul-27-21 05:48PM  
Jul-15-21 06:00AM  
Jul-14-21 08:00AM  
Jul-08-21 06:00AM  
Jun-24-21 04:01PM  
May-20-21 06:00AM  
May-18-21 09:00AM  
May-14-21 04:05PM  
May-11-21 10:55PM  
04:17PM  
May-06-21 06:15PM  
04:01PM  
02:45PM  
Apr-29-21 05:03PM  
Apr-22-21 06:00AM  
Apr-15-21 06:00AM  
Apr-06-21 02:13AM  
Mar-03-21 06:00AM  
Mar-02-21 07:55AM  
06:00AM  
Feb-25-21 04:05PM  
04:01PM  
02:30PM  
Feb-24-21 10:07AM  
Feb-22-21 04:01PM  
Feb-18-21 06:00AM  
Feb-16-21 06:00AM  
Feb-11-21 06:00AM  
Feb-05-21 07:45PM  
Jan-25-21 04:01PM  
Jan-06-21 12:45AM  
Dec-14-20 08:00AM  
Nov-19-20 06:00AM  
Nov-10-20 06:00AM  
Nov-07-20 08:00AM  
07:57AM  
Nov-04-20 05:15PM  
04:00PM  
02:30PM  
Oct-29-20 06:00AM  
Oct-28-20 12:32PM  
Oct-20-20 04:20PM  
08:00AM  
Oct-14-20 10:26AM  
06:00AM  
Oct-08-20 02:48PM  
Oct-07-20 04:00PM  
Oct-05-20 07:45PM  
08:00AM  
Sep-30-20 08:31AM  
07:36AM  
Sep-29-20 02:40PM  
10:29AM  
Sep-28-20 08:54PM  
12:20PM  
09:47AM  
Sep-24-20 06:00AM  
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN RAYMOND WChief Executive OfficerMar 29Sale60.0050,0003,000,000193,635Mar 31 08:04 PM
Kiernan Jane EDirectorMar 29Sale60.505,250317,6077,594Mar 31 08:04 PM
Noblett KarenChief Medical OfficerMar 18Sale57.2313,531774,35942,053Mar 22 08:52 PM
COHEN RAYMOND WChief Executive OfficerMar 14Sale52.8250,0002,641,148243,635Mar 16 09:13 PM
Dearen Danny L.See RemarksMar 01Option Exercise25.8212,329318,33540,564Mar 03 07:45 PM
Dearen Danny L.See RemarksMar 01Sale57.7019,9101,148,70920,654Mar 03 07:45 PM
Dearen Danny L.See RemarksFeb 25Option Exercise21.6610,000216,57638,235Mar 01 08:13 PM
Dearen Danny L.See RemarksFeb 25Sale57.0010,000570,00028,235Mar 01 08:13 PM
Woock JohnChief Marketing OfficerFeb 03Option Exercise0.0020,870067,227Feb 03 09:31 PM
Ford Alfred J JrChief Commercial OfficerFeb 03Option Exercise0.0024,130046,040Feb 03 09:31 PM
Dearen Danny L.See RemarksFeb 03Option Exercise0.0036,919046,919Feb 03 09:30 PM
COHEN RAYMOND WChief Executive OfficerFeb 03Option Exercise0.0096,8460374,750Feb 03 09:30 PM
Noblett KarenChief Medical OfficerFeb 03Option Exercise0.0019,463062,266Feb 03 09:32 PM
Sama RindaChief Operating OfficerFeb 03Option Exercise0.0029,311079,634Feb 03 09:32 PM
Noblett KarenChief Medical OfficerFeb 03Sale48.256,682322,42155,584Feb 03 09:32 PM
COHEN RAYMOND WChief Executive OfficerFeb 03Sale48.2535,1151,694,371339,635Feb 03 09:30 PM
Dearen Danny L.See RemarksFeb 03Sale48.2518,684901,54228,235Feb 03 09:30 PM
Ford Alfred J JrChief Commercial OfficerFeb 03Sale48.259,267447,15236,773Feb 03 09:31 PM
Woock JohnChief Marketing OfficerFeb 03Sale48.256,251301,62460,976Feb 03 09:31 PM
Sama RindaChief Operating OfficerFeb 03Sale48.2511,882573,33167,752Feb 03 09:32 PM
Dearen Danny L.See RemarksFeb 01Option Exercise14.1920,000283,80030,000Feb 03 09:30 PM
Dearen Danny L.See RemarksFeb 01Sale48.7020,000974,04810,000Feb 03 09:30 PM
Dearen Danny L.See RemarksJan 18Option Exercise8.3820,000167,53030,000Jan 20 09:13 PM
Dearen Danny L.See RemarksJan 18Sale50.9320,0001,018,54010,000Jan 20 09:13 PM
Woock JohnChief Marketing OfficerNov 15Option Exercise14.195,00070,95029,932Nov 17 09:16 PM
Woock JohnChief Marketing OfficerNov 15Sale60.485,000302,42124,932Nov 17 09:16 PM
COHEN RAYMOND WChief Executive OfficerSep 09Sale77.1150,0003,855,350234,607Sep 13 08:59 PM
Woock JohnChief Marketing OfficerSep 02Sale75.581,557117,67724,932Sep 03 06:52 PM
Woock JohnChief Marketing OfficerSep 01Option Exercise1.635,0008,15034,932Sep 03 06:52 PM
Woock JohnChief Marketing OfficerSep 01Sale74.738,443630,91526,489Sep 03 06:52 PM
Woock JohnChief Marketing OfficerAug 17Sale67.0025,0001,675,05429,932Aug 19 07:54 PM
Sama RindaChief Operating OfficerJun 11Option Exercise14.192,63837,43331,536Jun 16 08:53 PM
Sama RindaChief Operating OfficerJun 11Sale59.782,638157,70028,898Jun 16 08:53 PM
Sama RindaChief Operating OfficerJun 10Option Exercise14.191,36219,32730,260Jun 10 09:38 PM
Sama RindaChief Operating OfficerJun 10Sale60.021,36281,74728,898Jun 10 09:38 PM
Sama RindaChief Operating OfficerJun 08Option Exercise14.191,00014,19029,898Jun 10 09:38 PM
COHEN RAYMOND WChief Executive OfficerJun 08Sale60.0033,3331,999,980284,607Jun 10 09:37 PM
Sama RindaChief Operating OfficerJun 08Sale60.231,00060,23428,898Jun 10 09:38 PM
Dearen Danny L.See RemarksMay 21Option Exercise1.596,86610,88416,866May 24 08:45 PM
Dearen Danny L.See RemarksMay 21Sale55.226,866379,16410,000May 24 08:45 PM